Covered recipient · General Payments record
RAY T DOUGLAS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,413.11
- Reported across 193 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $556.97 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $224.06 | 9 |
| Lilly USA, LLC | $109.49 | 6 |
| Novo Nordisk AS | $74.71 | 4 |
| Acerta Pharma LLC | $55.80 | 3 |
| GlaxoSmithKline, LLC. | $34.44 | 2 |
| Amgen Inc. | $21.95 | 1 |
| PFIZER INC. | $19.57 | 1 |
| Phathom Pharmaceuticals, Inc. | $16.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.00 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103656430 | CMS |
| ABBVIE INC. | $16.03 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103656432 | CMS |
| ABBVIE INC. | $17.67 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103656434 | CMS |
| ABBVIE INC. | $8.16 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103656436 | CMS |
| ABBVIE INC. | $26.13 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103656438 | CMS |
| ABBVIE INC. | $31.28 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103656440 | CMS |
| ABBVIE INC. | $24.58 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103656442 | CMS |
| ABBVIE INC. | $32.89 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103656444 | CMS |
| ABBVIE INC. | $33.32 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103656446 | CMS |
| Amgen Inc. | $21.95 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117544026 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.51 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105430431 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.39 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104261043 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.90 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105614937 | CMS |
| GlaxoSmithKline, LLC. | $16.40 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116623955 | CMS |
| GlaxoSmithKline, LLC. | $18.04 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116334489 | CMS |
| Lilly USA, LLC | $20.17 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135370974 | CMS |
| Lilly USA, LLC | $16.82 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135380266 | CMS |
| Lilly USA, LLC | $18.93 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135380264 | CMS |
| Lilly USA, LLC | $15.86 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135355360 | CMS |
| Lilly USA, LLC | $19.81 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135352528 | CMS |
| Lilly USA, LLC | $17.90 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135362176 | CMS |
| Novo Nordisk Inc | $19.60 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097276705 | CMS |
| Novo Nordisk Inc | $16.07 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097634038 | CMS |
| Novo Nordisk Inc | $18.28 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097426283 | CMS |
| Novo Nordisk Inc | $20.76 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097629525 | CMS |
| PFIZER INC. | $19.57 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131963428 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.95 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151056691 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.